← Back
Cavalieri II Room
December, 02nd | 17:30 - 18:55
DRY AMD: TREATMENT
Add to calendar
Chairs: KASHANI AMIR H., MONES JORDI, YANNUZZI LAWRENCE
December, 02nd | 17:30 - 17:36
The Efficacy and Safety of Avacincaptad Pegol in Geographic Atrophy: 24-Month Results From GATHER2
VAJZOVIC LEJLA
Add to calendar
The Efficacy and Safety of Avacincaptad Pegol in Geographic Atrophy: 24-Month Results From GATHER2
VAJZOVIC LEJLA
Add to calendar
December, 02nd | 17:36 - 17:42
Inhibition of Pathologic Macrophage Activity — The Next Frontier in the Management of Geographic Atrophy Associated with AMD
HASSAN TAREK
Add to calendar
Inhibition of Pathologic Macrophage Activity — The Next Frontier in the Management of Geographic Atrophy Associated with AMD
HASSAN TAREK
Add to calendar
December, 02nd | 17:42 - 17:48
Complement inhibition of Geographic atrophy (GA)
BAUMAL CAROLINE
Add to calendar
Complement inhibition of Geographic atrophy (GA)
BAUMAL CAROLINE
Add to calendar
December, 02nd | 17:48 - 17:54
Complement Inhibitor therapy effect on RPE and PR integrity in Geographic Atrophy
SCHMIDT-ERFURTH URSULA
Add to calendar
Complement Inhibitor therapy effect on RPE and PR integrity in Geographic Atrophy
SCHMIDT-ERFURTH URSULA
Add to calendar
December, 02nd | 17:54 - 18:00
Long term safety (24- 36 months) in GA therapy & effects of baseline characteristics incl. fellow-eye involvement
TUFAIL ADNAN
Add to calendar
Long term safety (24- 36 months) in GA therapy & effects of baseline characteristics incl. fellow-eye involvement
TUFAIL ADNAN
Add to calendar
December, 02nd | 18:00 - 18:06
Safety of pegcetacoplan in the phase 3 OAKS and DERBY trials
MONES JORDI
Add to calendar
Safety of pegcetacoplan in the phase 3 OAKS and DERBY trials
MONES JORDI
Add to calendar
December, 02nd | 18:06 - 18:12
ONWARD Phase 2 Status Update on Oral Anti-Factor D (Danicopan) for Treatment of Geographic Atrophy due to Age Related Macular Degeneration–Masked Baseline Demographics
MOSHFEGHI DARIUS M.
Add to calendar
ONWARD Phase 2 Status Update on Oral Anti-Factor D (Danicopan) for Treatment of Geographic Atrophy due to Age Related Macular Degeneration–Masked Baseline Demographics
MOSHFEGHI DARIUS M.
Add to calendar
December, 02nd | 18:12 - 18:18
Metformin – an "old“ drug and its effect on ageing and dry AMD
AUGUSTIN ALBERT
Add to calendar
Metformin – an "old“ drug and its effect on ageing and dry AMD
AUGUSTIN ALBERT
Add to calendar
December, 02nd | 18:18 - 18:24
The Role of Photobiomodulation in the treatment of dry AMD
GISBERT RICHARD
Add to calendar
The Role of Photobiomodulation in the treatment of dry AMD
GISBERT RICHARD
Add to calendar
December, 02nd | 18:24 - 18:30
Preliminary one year results of PRIMAVERA, a multicenter study of vision restoration with implantation of a wireless chip in geographic atrophy
LE MER YANNICK
Add to calendar
Preliminary one year results of PRIMAVERA, a multicenter study of vision restoration with implantation of a wireless chip in geographic atrophy
LE MER YANNICK
Add to calendar
December, 02nd | 18:30 - 18:36
Subretinal PIXIUM chip implantation in geographic atrophy in AMD for bionic vision
SZURMAN PETER
Add to calendar
Subretinal PIXIUM chip implantation in geographic atrophy in AMD for bionic vision
SZURMAN PETER
Add to calendar
December, 02nd | 18:36 - 18:42
Cord Blood – Platelet Rich Plasma (CB-PRP) in Dry AMD
SAVASTANO ALFONSO
Add to calendar
Cord Blood – Platelet Rich Plasma (CB-PRP) in Dry AMD
SAVASTANO ALFONSO
Add to calendar
December, 02nd | 18:42 - 18:48
Gene Therapy for Neovascular and Atrophic AMD
HO ALLEN
Add to calendar
Gene Therapy for Neovascular and Atrophic AMD
HO ALLEN
Add to calendar
